Alaunos Therapeutics Files 2024 10-K/A Amendment
Ticker: TCRT · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1107421
| Field | Detail |
|---|---|
| Company | Alaunos Therapeutics, INC. (TCRT) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Alaunos Therapeutics filed its amended 2024 10-K. Check for updates.
AI Summary
Alaunos Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, formerly known as ZIOPHARM ONCOLOGY INC, is based in Houston, TX, and operates in the pharmaceutical preparations industry. This filing provides updated information for the period ending December 31, 2024.
Why It Matters
This amendment to the annual report provides updated financial and operational information for investors and stakeholders, reflecting the company's status as of December 31, 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Alaunos Therapeutics is subject to inherent risks in drug development, regulatory approvals, and market competition.
Key Numbers
- 001-33038 — SEC File Number (Identifies the company's filings with the SEC.)
- 84-1475642 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- Alaunos Therapeutics, Inc. (company) — Registrant
- ZIOPHARM ONCOLOGY INC (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 2025-04-30 (date) — Filing date
- Houston, TX (location) — Principal executive address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing is an amendment to the annual report for the fiscal year ended December 31, 2024, providing updated information.
What was Alaunos Therapeutics, Inc. formerly known as?
Alaunos Therapeutics, Inc. was formerly known as ZIOPHARM ONCOLOGY INC.
When is the fiscal year end reported in this filing?
The fiscal year end reported in this filing is December 31, 2024.
Where is Alaunos Therapeutics, Inc. headquartered?
Alaunos Therapeutics, Inc.'s principal executive address is 2617 Bissonnet Street, Suite 233, Houston, TX 77005.
What is the SEC file number for Alaunos Therapeutics, Inc.?
The SEC file number for Alaunos Therapeutics, Inc. is 001-33038.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Alaunos Therapeutics, Inc. (TCRT).